310 related articles for article (PubMed ID: 3439185)
1. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
Frenken LA; Verberckmoes R; Michielsen P; Koene RA
Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
[TBL] [Abstract][Full Text] [Related]
5. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
6. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
7. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
8. Who should receive recombinant human erythropoietin?
Van Stone JC
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
Borrego FJ; Miguel JL; Zamorano A; Muñoz J; Bajo A; López-Revuelta K; Sánchez Sicilia L
Med Clin (Barc); 1991 Nov; 97(18):687-92. PubMed ID: 1770818
[TBL] [Abstract][Full Text] [Related]
11. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for recombinant human erythropoietin therapy.
Eschbach JW; Adamson JW
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC
Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424
[TBL] [Abstract][Full Text] [Related]
15. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
[TBL] [Abstract][Full Text] [Related]
16. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
17. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
Wiecek A; Kokot F; Grzeszczak W; Klin M
Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
